FIELD: organic chemistry, chemical technology, medicine, pharmacy.
SUBSTANCE: invention relates to new derivatives of piperazinylalkylthiopyrimidine of the formula (I): wherein R1 represents hydrogen atom, (C1-C4)-alkyl, (C1-C4)-alkanoyl or di-(C1-C4-alkyl)-amino-(C1-C4-alkyl); R2 means hydrogen atom or benzyl substituted with 1-3 substitutes taken among the group consisting of (C1-C4)-alkyl, (C1-C4)-alkoxy-group, di-(C1-C4-alkyl)-amino-group, hydroxyl group and halogen atom; n = 2, 3 or 4, and to its pharmaceutically acceptable acid addition salt. Also, invention describes a method for preparing compounds and pharmaceutical composition based on thereof. Compounds are useful for treatment of diseases arising as result of the central nervous system injury.
EFFECT: improved preparing method, valuable medicinal properties of compounds.
14 cl, 3 tbl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS AND INTERMEDIATE COMPOUNDS FOR PREPARING IMATINIB, OPTIONALLY RADIOLABELLED | 2006 |
|
RU2440999C2 |
IMIDAZOPYRAZINES | 2012 |
|
RU2600327C2 |
PIPERIDINE- AND PIPERAZINE-SUBSTITUTED N-HYDROXYFORMAMIDES AS INHIBITORS OF METALLOPROTEINASES | 2001 |
|
RU2283306C2 |
6,7,8,9-SUBSTITUTED 1-PHENYL-1,5-DIHYDROPYRIDO (3,2-b) INDOLE-2-ONES EFFECTIVE AS ANTIINFECTIOUS PHARMACEUTICAL AGENTS | 2005 |
|
RU2377243C2 |
DERIVATIVES OF THIOXANTHINE AS MYELOPEROXIDASE INHIBITORS | 2003 |
|
RU2323219C2 |
METHOD FOR PRODUCTION OF HYDROXYLATED CYCLOPENTYL PYRIMIDINE COMPOUNDS | 2013 |
|
RU2643811C2 |
OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2815636C1 |
COMPOUNDS USED AS ATR KINASE INHIBITORS | 2013 |
|
RU2689996C2 |
NEW INHIBITOR BASED ON A QUINOLINE DERIVATIVE | 2019 |
|
RU2802283C2 |
1,5,6-SUBSTITUTED 2-OXO-3-CYANO-1,6A-DIAZATETRAHYDROFLUORANTHENES | 2006 |
|
RU2389730C2 |
Authors
Dates
2005-01-27—Published
2000-06-29—Filed